Effect of chlorambucil on bone mineral density in the course of chronic lymphoid leukemia

European Journal of Haematology

Volumn 61, Issue 2, 1998, Pages 135-139

  Leone, J ^a   Vilque, J P ^a   Jolly, D ^a   Pignon, B ^a   Biaise, A M ^a   Pennaforte, J L ^a   Eschard, J P ^a   Etienne, J C ^a  

^a SERVICE DE DERMATOLOGIE   (France)

Author keywords

Bone mineral density; Chlorambucil; Chronic lymphoid leukemia

Indexed keywords

CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DAUNORUBICIN; PREDNISOLONE; VINCRISTINE SULFATE;

ADULT; AGED; ARTICLE; BONE DENSITY; CANCER COMBINATION CHEMOTHERAPY; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL;

EID: 0031876834     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1998.tb01074.x     Document Type: Article

References (15)

1. BINET JL, AUQUIER A, DIGHIERO G, et al. A new pronostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981: 48: 198-206.
2. MARCELLI C, CHAPPARD D, ROSSI JF, et al. Histologic evidence of an anormal bone remodeling in B-cell malignancies other than multiple myeloma. Cancer 1988: 62: 1163-1170.
3. ROSSI JF, BATTAILLE R, CHAPPARD D, ALEXANDRE C, JANBON C. B-cell malignancies presenting with unusual bone involvement and mimicking multiple myeloma. Am J Med 1987: 83: 10-16.
4. ROSSI JF, CHAPPARD D, MARCELLI C, et al. Micro-osteoclast resorption as a characteristic feature of B-cell malignancies other than multiple myeloma. Br J Haematol 1990: 76: 469-475.
5. Dixon WJ. BMDP Statistical software manual, Volumes I and II. Edited by WJ Dixon. Davis, CA: University of California Press, 1990.
6. MEYER R, KIEFFER D, VAUTRAVERS PH, KUNTZ J-L, ASCH L. Atteintes osseuses au cours des leucoses lymphoïdes chroniques. A propos d'une observation. Rev Rhum 1980: 47: 651-655.
7. BONVOISIN B, BOUVIER M, MEUNIER PJ. Leucémie lymphoïde aver raréfaction osseuse par hyperostéoclastose juxtalymphocytaire. Presse Méd 1980: 9: 1932.
8. RATCLIFFE MA, LANHAM SA, REID DM, DAWSON AA. Bone mineral density in patients with lymphoma: the effects of chemotherapy, intermittent corticosteroids and premature menopause. Haematol Oncol 1992: 10: 181-187.
9. DEVRED C, DIEBOLD J. La myélofibrose au cours des hémopathies. Valeur diagnostique et pronostique. A propos de 402 observations. Sem Hôp Paris 1974: 50: 1625-1634.
10. LENNARD AL, PROCTOR SJ. Chronic lymphocytic leukaemia terminating in acute myelofibrosis. J Clin Pathol 1984: 37: 564-567.
11. GISSER DS, CHUNG KB. Acute myelofibrosis in progressive sytemic sclerosis. Report of a case developing during long-term chlorambucil therapy and discussion of pathogenic factors. Am J Med 1979: 67: 151-154.
12. NAJMAN A, GORIN NC, DUHAMEL G, ROGER M, DRY J. Myélofibrose aiguë après traitement prolongé d'une sclérose en plaques par le chlorambucil. Presse Méd 1980: 9: 1897.
13. GAMINARA EJ, PEARSON TC. Chlorambucil-induced myelofibrosis. Case report. Clin Lab Haematol 1984: 6: 293-237.
14. KIMURA A, HYODO H, NAKATA Y, KURAMOTO A. Chronic lymphocytic leukemia associated with bone marrow fibrosis: possible role of interleukin 1 alpha in the pathogenesis. Am J Hematol 1993: 43: 47-50.
15. NAJFAN Y, DRESCH C, RAIN JD. The very-long-term course of polycythaemia: a complement to the previously published data of the Polycythaemia Vera Study Group. Br J Haematol 1994: 86: 233-235.